Tamoxifen reduces breast cancer rate in at-risk healthy women by nearly a third, finds studyBMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g7596 (Published 12 December 2014) Cite this as: BMJ 2014;349:g7596
- Zosia Kmietowicz
- 1The BMJ
Taking tamoxifen for five years has been found to reduce the rate of breast cancer by 29% among healthy women at high risk of developing the disease, a long term study has found.
Between 1992 and 2001 7154 women aged 35-70 with an increased risk of breast cancer, primarily because they had a family history, were enrolled into the International Breast Cancer Intervention Study I and were randomly allocated to receive either tamoxifen (3579) or placebo (3575) for five years. Researchers continued to track the health of all …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial